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1088Objective: To determine the safety, efficacy, and frequency of side graft axillary artery cannulation for extra-
corporeal membrane oxygenation support and compare it with other cannulation techniques.
Methods: From January 2001 to October 2011, 308 adult patients were supported with extracorporeal mem-
brane oxygenation at a single center. In 81 patients (26.3%), the extracorporeal membrane oxygenation circuit
was composed of an arterial inflow by a side graft sewn to the axillary artery. Of the 308 patients, 166 (53.9%)
underwent femoral arterial cannulation and 61 (19.8%) underwent ascending aortic cannulation The pertinent
variables and postprocedural events were retrospectively analyzed in this cohort of patients.
Results: The most common complication in the axillary artery group was hyperperfusion syndrome of the ip-
silateral upper extremity (n¼ 20, 24.7%), followed by bleeding from the arterial outflow graft (n¼ 14, 17.3%).
Lower extremity ischemia and fasciotomy were more frequent after femoral arterial cannulation (n ¼ 27, 16%,
and n ¼ 18, 10.8%, respectively). The predictors for a poor in-hospital outcome for the entire group of patients
were age and postoperative cerebral vascular accident. The cannulationmethod was not a predictor of in-hospital
outcomes.
Conclusions: Extracorporeal membrane oxygenation support with side graft axillary artery technique was more
frequently associated with hyperperfusion syndrome than other cannulation sites. Lower extremity ischemia and
compartment syndrome was more common after femoral arterial cannulation. (J Thorac Cardiovasc Surg
2013;145:1088-92)The indications for extracorporeal membrane oxygenation
(ECMO) have been well established.1-3 Access for the
initiation of ECMO can be challenging, and a number
of approaches have been reported. For patients with
postcardiotomy shock, central cannulation is typically used,
because it is easy to switch the cardiopulmonary bypass
circuit to ECMO with the existing cannulas. Alternatively,
in cases in which immediate support is necessary, such
as acute cardiogenic shock after myocardial infarction,
percutaneous access can be achieved by way of a peripheral
vessel using the Seldinger technique or open arteriotomy.
The disadvantages of the latter approaches lie in the inter-
ference of distal flow to the cannulated limb, resulting in is-
chemia. This has previously been reported as a common
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The Journal of Thoracic and Cardiovascular Suran effort to minimize this, some have proposed using distal
perfusion cannulas to guarantee limb perfusion or placing
a side graft on the target artery.4
We have previously reported on the use of a side graft
on the axillary artery as a choice for ECMO.5 The
advantages to using this vessel include the lack of athero-
sclerosis, the guarantee of forward flow into the aorta, po-
tentially minimizing atherosclerotic embolization, and the
preferential delivery of oxygenated blood to the heart and
brain. However, although our initial report focused on the
feasibility of using this technique for ECMO, the out-
comes associated with this cannulation strategy have never
been studied. Therefore, the purpose of the present study
was to analyze the outcomes associated with the use of
a side graft on the axillary artery as a cannulation tech-
nique for venoarterial (VA) ECMO in a large patient
cohort.MATERIALS AND METHODS
A retrospective chart review was conducted of all patients who had re-
ceived ECMO from January 2001 to October 2011 at Cleveland Clinic
Foundation (Cleveland, Ohio). A review of patient charts provided demo-
graphics, the indication for VAECMO support, duration of support, ECMO
flow (documented at the first instance after ECMO initiation), partial oxy-
gen arterial pressure measured within 4 hours after ECMO initiation, and
short- and long-term outcomes, including limb complications related to ar-
terial cannulation. The institutional review board provided written approval
for the present study.gery c April 2013
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MCannulation Strategy and Technique
The arterial cannulation strategy varied from case to case. For patients
with ongoing chest compression, we used femoral arterial cannulation per-
cutaneously placed for VA ECMO support. For postcardiotomy cases, we
preferred central aortic cannulation as the first choice. However, if the ax-
illary artery had been previously exposed before sternal entry in redo ster-
notomy cases or complex aortic arch reconstruction requiring deep
hypothermia with antegrade cerebral perfusion was undertaken, we used
the axillary artery.
The technique of side grafting the axillary artery for VA ECMO support
has been previously described.6 In brief, the axillary artery was exposed be-
low the clavicle, and, after administration of 5000 U of heparin, an 8-mm
hemashield graft was sewn in an end-to-side fashion. Venous drainage was
achieved with either a long 20F or 24F cannula (Edward Lifesciences, Ir-
vine, Calif) placed in the common femoral vein or right atrium when the
chest was left open after median sternotomy.
ECMO Management
The intensive care unit protocol for VAECMOpatients in our institution
has been previously reported.7 A heparin infusion was initiated at 400 U/hr
once the chest was closed and all major bleeding had subsided, targeting
a partial thromboplastin time of 55 to 65 seconds. If a patient could main-
tain appropriate hemodynamics and respiratory function with minimal ino-
tropic support, the patient was considered for ECMO separation. Also, it
was necessary to withdraw ECMO support if survival was unlikely.
Definitions
Hyperperfusion syndromewas defined as an ipsilateral, to the side of the
arterial cannulation, edematous limb that was hyperemic and warm to
touch. Compartment syndrome was defined as the more serious presenta-
tion of hyperperfusion syndrome in which the high compartment pressure
causes secondary extremity ischemia. Arm ischemia was defined as a cold,
pale, and/or mottled ipsilateral extremity due to decreased arterial blood
flow. For the purposes of the present analysis, bleeding was considered
present if exploration of the axillary artery cannulation site was necessary.
Finally, stroke was defined as any central neurologic deficit diagnosed by
clinical examination and/or radiologic imaging.
Statistical Analysis
Continuous variables are expressed as the mean values  standard de-
viation and were compared using the t test. Categorical values are ex-
pressed as percentages and were compared using the c2 test or Fisher’s
exact test, as appropriate. Multivariate regression analysis for in-hospital
survival was undertaken for the entire group of patients receiving VA
ECMO support. The variables of the entire group of patients were evalu-
ated, first using univariate and then multivariate analysis. Model selection
was donewith a backward stepwisemethod, starting from all variables with
a P value<.05 on univariate analysis. The model was confirmed using for-
ward selection.RESULTS
Indications for VA ECMO
From January 2001 to October 2011, 429 patients under-
went ECMO support for a variety of diagnoses at ourThe Journal of Thoracic and Carinstitution. Of the 429 patients, 62 received venovenous
ECMO for respiratory failure, and 26 received right ventric-
ular support during left ventricular assist device placement
for temporary right ventricular failure. Of the 341 patients
receiving VA ECMO support, 33 did not have sufficient
data for statistical analysis and were excluded from the
present retrospective review.
Of the 308 patients who constituted the basis of our re-
view, 81 underwent axillary cannulation (26.3%), 166
(53.9%) underwent femoral arterial cannulation, and 61
(19.8%) underwent ascending aortic cannulation. The indi-
cations for ECMO support included postcardiotomy shock
after major cardiac procedures (n ¼ 173, 56.2%), postin-
farction cardiogenic shock (n ¼ 55, 17.9%), decompen-
sated cardiomyopathy (n ¼ 44, 14.3%), respiratory
failure (n ¼ 21, 6.8%), and various other reasons
(n ¼ 15, 4.9%; Table 1).
Arterial Cannulation Complications
Hyperperfusion syndrome was more common with the
use of a side graft on the axillary artery (n ¼ 20,
24.7%; Table 1). Of the 20 patients who developed hyper-
perfusion syndrome, 4 developed compartment syndrome
of the limb. In 6 cases, the arterial outflow site had to
be relocated (3 to the femoral artery, 2 to the aorta, and
1 to the contralateral axillary artery). These procedures
were performed because compartment syndrome devel-
oped despite nonoperative management. Although 2 pa-
tients required upper extremity fasciotomy for
compartment syndrome despite graft relocation, no addi-
tional action was taken for 2 other patients because of
multisystem organ failure progression. Five patients with
hyperperfusion of an upper extremity had arterial bleeding
from the axillary side graft compromising the venous
drainage. In 3 cases, arm swelling was effectively treated
with wound exploration and hematoma evacuation. An-
other patient had proximal innominate artery stenosis
that was missed preoperatively. Nine patients continued
to have noncritical arm swelling that was effectively ad-
dressed with arm elevation. With additional analysis of
the axillary artery patient group, we did not identify any
variables that were specifically related to the hyperperfu-
sion group. Furthermore, ECMO flow was not different
between the hyperperfusion and the nonswollen arm group
(3.6  0.67 vs 3.5  0.93 L/min, respectively; P ¼ .681).
Bleeding from the cannulation site was more common
after axillary artery cannulation (n ¼ 14, 17.3%); it typi-
cally occurred within 24 hours after VA ECMO initiation.
This complication was treated with surgical exploration, he-
matoma evacuation, and control of bleeding by suturing
anastomotic bleeding points. In cases of generalized coa-
gulopathy, blood product transfusion was necessary, along
with application of topical hemostatic agents and drain
placement in the surgical wound.diovascular Surgery c Volume 145, Number 4 1089
TABLE 1. Patient characteristics
Variable
Axillary
(n ¼ 81)
Femoral
(n ¼ 166)
Central
(n ¼ 61)
P
value
Demographics
Men 47 (58) 119 (71.7) 31 (50.8) .006
Age (y) 60.3  15.6 56.4  14.7 62.1  13.6 .018
HTN 48 (59.3) 63 (38) 37 (60.7) .001
PVD 10 (12.3) 14 (8.4) 8 (13.1) NS
CVA 5 (6.2) 9 (5.4) 2 (3.3) NS
Renal failure 5 (6.2) 35 (20.9) 11 (18) .011
Indication
After cardiotomy 50 (61.7) 66 (39.8) 57 (93.4) <.001
After infarction 13 (16) 41 (24.7) 1 (1.6) <.001
Cardiomyopathy 4 (4.9) 39 (23.5) 1 (1.6) <.001
Respiratory failure 11 (13.6) 9 (5.4) 1 (1.6) .012
Other 3 (3.7) 11 (6.6) 1 (1.6) NS
Outcome
In-hospital mortality 62 (76.5) 107 (64.5) 41 (67.2) NS
CVA (postoperative) 5 (6.2) 32 (19.3) 13 (21.3) .016
Limb complications
Hyperperfusion 20 (24.7) 8 (4.9) 1 (1.6) <.001
Ischemia 1 (1.2) 27 (16.3) 3 (4.9) <.001
Fasciotomy 2 (2.5) 18 (10.8) 2 (3.3) .024
Bleeding 14 (17.3) 9 (5.4) 1 (1.6) .001
Data presented as n (%) or mean  standard deviation. CVA, Cerebral vascular acci-
dent; HTN, hypertension; NS, not significant; PVD, peripheral vascular disease.
TABLE 3. Multivariate analysis for in-hospital survival of patients
supported with VA ECMO
Variable OR 95% CI P value
Age 1.036 1.018-1.054 <.001
Postoperative CVA 2.340 1.067-5.129 .034
CI, Confidence interval; CVA, cerebral vascular accident; ECMO, extracorporeal
membrane oxygenation; VA, venoarterial.
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MLower extremity ischemia was more common after fem-
oral cannulation. Finally, the frequency of lower extremity
fasciotomy for compartment syndrome was greater after
femoral cannulation (Table 1).
Weaning and Survival
Of the 308 patients supported with VA ECMO, 98
(31.8%) survived to hospital discharge. Univariate analysis
identified age, hypertension, postoperative cerebral vascu-
lar accident, and cardiomyopathy as independent predictors
for in-hospital outcome (Table 2). Age and postoperative
cerebral vascular accident were independent predictors for
a poor outcome on multivariate analysis (Table 3). The can-
nulation method was not an in-hospital outcome predictor.
For postinfarction and postcardiotomy cases, achieving
adequate left ventricular decompression is very importantTABLE 2. Univariate analysis for in-hospital survival of patients
supported with VA ECMO
Variable OR 95% CI P value
Age 1.036 1.019-1.054 <.001
Hypertension 2.146 1.019-1.054 .003
PVD 3.782 1.288-11.105 .016
Cardiomyopathy 0.503 0.263-0.964 .038
Postoperative CVA 2.399 1.116-5.160 .025
CI, Confidence interval; CVA, cerebral vascular accident; ECMO, extracorporeal
membrane oxygenation; OR, odds ratio; PVD, peripheral vascular disease; VA, ve-
noarterial.
1090 The Journal of Thoracic and Cardiovascular Surto increase the chance of successful weaning from
ECMO. Adequate venous drainage with the largest possible
venous cannula size prevents cardiac distention; however,
this occurs in a large number of patients. In patients with se-
vere pulmonary edema, left atrial or pulmonary artery de-
compression is an option. In our group, 4 patients (1.3%)
developed severe pulmonary edema from left ventricular
distention. Pulmonary artery (2 cases) and left atrial decom-
pression with a transeptal approach (2 cases) was performed
with a percutaneously placed 20F cannula (Edward Life-
sciences) from the common femoral or internal jugular vein.
Of the 81 patients with an axillary side graft, 25 (30.9%)
were successfully weaned fromVAECMO, and of those, 14
patients (17.3%) survived to hospital discharge. Another 14
patients (17.3%) were successfully bridged to a mechanical
circulatory support device (n ¼ 8) or transplantation (lung
in 4, heart in 1, and heart and lung in 1). Of the patients
whowere bridged to a ventricular assist device or transplan-
tation, 5 (6.2%) survived to hospital discharge. The overall
survival to discharge was 23.5% (n¼ 19). The causes of in-
hospital death included multiorgan system failure in 57
(70.4%) and stroke in 5 (6.2%).
Of the 19 patients with an axillary artery side graft who
survived, 2 (2.5%) developed brachial plexopathy that im-
proved with time. No cases of axillary graft stump infection
or ipsilateral upper extremity ischemia had developed at the
last follow-up examination (mean, 6.6 months).Adequacy of VA ECMO Support Provided by
Axillary Cannulation
The adequacy of support provided by the axillary artery
was assessed according to the ECMO flow and partial oxy-
gen arterial pressure within 4 hours after ECMO initiation.
No ECMO flow difference (3.53  0.86 vs 3.73  0.86 L/
min, respectively, P ¼ .117) was seen between the axillary
group and entire group supported using the 3 different arte-
rial cannulation techniques. Similarly, no partial oxygen ar-
terial pressure difference was found between the 2 groups
(309.89  85.19 vs 326.89  102.78 mm Hg; P ¼ .172).DISCUSSION
The most significant finding associated with the present
study was the previously unreported complication of hyper-
perfusion syndrome associated with using a side graft tech-
nique on the axillary artery as an outflow site for VA ECMOgery c April 2013
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Msupport. This event occurred in nearly 20% of the patients,
with almost one half of those requiring some type of inter-
vention to treat compartment syndrome. However, the inci-
dence of extremity ischemia and compartment syndrome
was greater with femoral cannulation.
The reasons for the development of hyperperfusion syn-
drome are multiple and can be broadly divided into 2 cate-
gories: (1) those causes resulting from arterial outflow
obstruction; and (2) those associated with venous outflow
obstruction. Among the arterial obstructive causes, the tech-
nical problems associated with construction of the anasto-
mosis between the side graft and axillary artery is one
issue. If, while creating the side graft to artery anastomosis,
a problem occurs with the toe portion of this procedure, an
axillary artery can be narrowed, causing a reduction in lumen
size. This can result in preferential flow down the arm. A
similar pattern can be expected with prolonged axillary graft
use on the axillary artery in patients with atherosclerotic aor-
tic arch disease and/or acute type A dissections in which the
head vessels are involved. Venous obstructive causes can in-
clude bleeding into the surrounding space, causing a com-
pressive hematoma, or if drainage to the arm is impeded
by either a venous cannula or deep vein thrombus, or both.
How to respond to hyperperfusion syndrome is equally as
important as diagnosing it because, as noted in our experi-
ence, a portion of these patients can develop ipsilateral
upper extremity compartment syndrome. The initial man-
agement of hyperperfusion syndrome should be guided de-
pending on its etiology. If arterial causes are suspected, the
initial management should include (1) elevating the arm and
(2) decreasing ECMO flow. The latter maneuver is done to
balance adequate end-organ perfusion and capillary pres-
sure in the affected arm. If these maneuvers fail to relieve
the syndrome, and concerns regarding the condition of the
arm continue to occur, an effort to relocate the outflow for
the VA-ECMO should be pursued.
If the cause of hyperperfusion syndrome is venous ob-
struction, therapy should be aimed at addressing the etiol-
ogy causing the decreased venous return. For cases in
which bleeding is the cause, evacuation of the hematoma
impinging on the axillary vein should be performed and
wide drainage achieved with sump catheters. Close inspec-
tion of the anastomosis is warranted in these cases, because
continued bleeding from the arterial anastomotic site will
perpetuate the problem. In cases in which a cannula is
placed in the axillary vein for VA-ECMO drainage, another
vein should be selected for cannulation—preferably the
femoral vein. For patients in whom deep venous thrombosis
is suspected, or diagnosed by radiologic modalities, no
alternative is possible other than changing the arterial can-
nulation site, as previously described. It is important to note
that the venous outflow can also be impeded in cases of car-
diac tamponade and relieving this problemwill also assist in
upper extremity drainage.The Journal of Thoracic and CarAlthough, ideally, most patients would undergo a workup
preoperatively before the axillary artery is used for cannu-
lation, the reality is that most patients present in such an
acute state that a thorough radiologic investigation of
some of these etiologies is never performed, and most are
diagnosed only later. Nonetheless, it is important to keep
these events in mind, because at the point of consultation,
a good vascular history can provide insight regarding the
potential of developing hyperperfusion syndrome after axil-
lary artery cannulation.
It was reassuring to find that the incidence of other ad-
verse events associated with axillary artery side grafting
for VA ECMO was not high. The incident of stroke with
this technique in our series was 6.2%, lower than that of
other published reports on ECMO using different cannula-
tion strategies.8 It is imperative to note that a number of
other factors can cause stroke, notwithstanding complex
surgical procedures and/or the volatile hemodynamic fluc-
tuations seen in patients who need ECMO support.
The incidence of upper extremity neurologic and stump
graft infection as adverse events at the last follow-up visit
was also low. Although neuropraxy did develop in our se-
ries, they were few and not permanent and resolved with
a combination of physical therapy and expectant waiting.
Finally, an important point that should be underscored
from this experience is that the findings we have reported
might be relevant when considering the use of the side
graft axillary artery technique to establish long-term me-
chanical circulatory support. For instance, with left ventric-
ular assist devices becoming smaller, and the population of
patients with ischemic cardiomyopathy increasing, proce-
dures could evolve for using this anastomotic technique
as a location for the left ventricular assist device outflow
graft when using limited incisions. It is reasonable to be-
lieve that some surgeons might use it, in particular, for
cases in which a patient has undergone previous sternot-
omy and, as a result, the surgeon might want to avoid ster-
nal re-entry. In such cases, a thorough workup would be
needed to avoid hyperperfusion syndrome if the axillary ar-
tery is selected as the target vessel for left ventricular assist
device drainage.
CONCLUSIONS
The axillary artery side graft is more frequently associ-
ated with hyperperfusion syndrome in VA ECMO. Lower
extremity ischemia and compartment syndrome are more
common after femoral arterial cannulation. Continuous
surveillance is necessary to identify complications early,
and surgical revision could be required to manage those
complications.References
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